Delivery Order SPE2DB22D1106-SPE2DB24FFKX9

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Corlanor 5 mg tablets. The contract has a firm fixed price of $3,754.23 and an ultimate completion date of June 24, 2025. The award is not set aside and provides for the delivery of pharmaceutical products to support military and government healthcare programs. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Corlanor 5 mg tablets. The contract has a firm fixed price of $3,995.82 and a period of performance through June 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Corlanor 5 mg tablets, a prescription medication, with a ceiling value of $1,415.18 and a performance period ending on July 2, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp. holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,809.83, is for the supply of 4,568,108,411 units of the medication Corlanor 5 mg tablet. The contract has an ultimate completion date of May 2, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Corlanor 5 mg tablets. The contract has a ceiling value of $5,070.39 and is a firm fixed-price delivery order without any set-aside designation, indicating open competition. The contract has an ultimate completion date of May 2, 2025 and was awarded on May 1, 2025. AmerisourceBergen Drug Corp, based in...
This is a Delivery Order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CORLANOR 7.5 MG TABLET 60S, a prescription medication. The award, valued at $2,151.89, is a Firm Fixed Price contract with an ultimate completion date of August 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Corlanor 5 mg tablets and has a ceiling value of $26,022.62. The ultimate completion date is March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of Corlanor 5 mg tablets, a prescription medication, to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has a ceiling value of $3,749.41 and a performance period through March 13, 2024. The...
This is a $5,253.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for the supply of 4565632370 - CORLANOR 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of August 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as a firm fixed price delivery order for the supply of Corlanor 5 mg tablets. The total ceiling value of the award is $2,114.52, with a period of performance through April 2, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to $999,999,999.00 and...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFKX9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Corlanor 5 mg tablets. The contract has a firm fixed price of $2,894.22 and a completion date of September 5, 2024. The contract is not set aside and is issued as a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to support military treatment programs and facilities worldwide.

Generated 12/4/24, 9:31 AM